Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Ind Diagnostic, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

112 daysmedian FDA review time
551 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K103037IND URINARY TRACT INFECTION (UTI) TEST STRIPSInd Diagnostic, Inc.2012-04-175511
K100031IND ONE STEP FECAL OCCULT BLOOD TEST MODEL 440-10Ind Diagnostic, Inc.2010-07-191940
K063390URINE CHEMISTRY ANALYZER UR-50Ind Diagnostic, Inc.2007-03-011120
K060810ONE STEP DRUG TEST - AMP/MET/MOR/THC/COCInd Diagnostic, Inc.2006-08-071360
K052694ONE STEP HCG PREGNANCY TEST - 2000 MIU/ML, MODEL 100 SERIES.Ind Diagnostic, Inc.2005-12-16790
K052662ONE STEP FSH MENOPAUSAL TESTInd Diagnostic, Inc.2005-11-30641
K050741IND ONE STEP HCG PREGNANCY TEST - CASSETTE FORMATInd Diagnostic, Inc.2005-05-16563
K023638CASSETTE/URINE HCGInd Diagnostic, Inc.2003-01-03650

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda